Here is a quick primer on currently available MS therapies for partners in a patient’s healthcare team and also for patients.
Heidi Moawad, MD
This large population subset can potentially benefit from therapies that are more directly targeted to hormonally-influenced migraine headaches.
Who is most likely to be affected by Alice in Wonderland syndrome? Would you consider a toxicology screen or neuroimaging for afflicted patients?
How do you approach the management of patients with multiple sclerosis and another autoimmune condition, such as psoriasis?
How important do you consider cognitive rest in the management of TBI? How long do you recommend cognitive rest in patients with mild TBI?
Cannabis may be useful for some types of refractory epilepsy, but few controlled studies with objective measures of efficacy and side effects exist.
A self-degrading implantable device for the brain may potentially ease some of the challenges of managing TBIs and other neurological emergencies.
Does prophylactic onabotulinumtoxinA benefit patients with migraine or are they experiencing a placebo effect?
Does it matter whether the medications we prescribe to patients are generated via the most cutting edge 3D printing technology?
Compliance, an obstacle in depression treatment for all patients, can be especially difficult for patients with dementia.